Necrotising Enterocolitis Market Research Report – Forecast to 2027

Necrotising Enterocolitis (NEC) Market Research Report: By Stages (Stage I, Stage II, Stage III), Diagnosis (Imaging, Laboratory Studies), Treatment (TPN, Paracentesis, Antifungal) End-User (Hospital & Clinic, Diagnostic Center)-Forecast Till 2027

ID: MRFR/Pharma/4541-HCR | December 2022 | Region: Global | 100 Pages         

Necrotising Enterocolitis Market Speak to Analyst Request a Free Sample

Necrotizing Enterocolitis Market Overview:


The necrotizing enterocolitis market is one of the rapidly improving market structures which is projected to achieve better future results due to the rising number of cases of morbidity and mortality among infants and premature babies which leads to continuous investments being made towards the establishment and growth of the necrotizing enterocolitis market size and share.


Necrotizing Enterocolitis is a form of severe inflammation caused in the inner lining of the intestinal wall. Due to such inflammation, a hole is formed on the intestinal wall due to which there is a leakage of usual bacteria which are present in the intestine for better digestion to the abdomen and other body parts and hence causes infection to other body organs. The infection spreads in the entire body and creates a medical emergency and if not treated properly can also be life-threatening and in adverse situations may also cause the death of the baby.


Necrotizing Enterocolitis is said to affect newborn babies particularly within one week of their birth. The most common symptoms of a baby suffering from necrotizing enterocolitis are poor tolerance to feelings, blood in stool, redness in the stomach region, and in extreme cases it can also lead to apnea and sleep disorders. Rapid investments in terms of technology and logistics have provided a major boost to the necrotizing enterocolitis market


The global necrotizing enterocolitis market is expected to grow at a CAGR of around 5.5% due to a number of drivers acting in favor of the market. The necrotizing enterocolitis market is expected to reap positive results from the Asia Pacific region where the demand for necrotizing enterocolitis is expected to be high due to a large proportion of the newborns and infants residing in these countries and the increasing number of cases of necrotizing enterocolitis in the countries of these regions. Moreover, the segment by application is expected to contribute maximum towards market share.


COVID 19 Analysis:


The covid 19 pandemic has affected every market in one way or the other and similarly, it has affected the necrotizing enterocolitis markets also in a way that even after the symptoms of the infections are discovered people are avoiding visits to hospitals except in cases of emergency, having treatment inside their homes due to forced lockdowns which have reduced the need for necrotizing enterocolitis equipment in the healthcare sector. Due to the Covid 19 effect, it has been observed that a large number of necrotizing enterocolitis companies are forced to lay off employees but it is assumed that the market will soon pick up the pace and the demand would increase. It is expected that the post-lockdown period would be a great success for the necrotizing enterocolitis market revenue since the pending necrotizing enterocolitis treatment surgeries would provide a sudden increase to the global market scenario. It is also analyzed that every segment would be contributing significantly towards the growth of market value.


MARKET DYNAMICS


Drivers:


The necrotizing enterocolitis market has been experiencing a diversified growth in all segments and across different regions due to the rising populations and the increasing per capita incomes of people which has shifted the demands of people to highly sophisticated and technologically advanced products and equipment which have acted as a motivating factor to the necrotizing enterocolitis market.


Secondly, easy availability of medicines and drugs for the treatment of necrotizing enterocolitis along with improved regulatory framework by the Government towards the development of new antibiotics and therapies to diminish the effect of necrotizing enterocolitis in newborn babies has given a significant drive to necrotizing enterocolitis market.


Apart from this, increased research funding and initiatives by the Government of a number of countries have given a needed fuel to the necrotizing enterocolitis treatment market as this has now become a matter of public concern and health and the Governments would not want newborn babies dying in their countries due to lack of healthcare services. Thus, there have been continuous improvements in the treatment of necrotizing enterocolitis globally.


Restraints:


The overall growth in the necrotizing enterocolitis market has been expediently rising but certain factors hinder the growth process of the market which include large sums of money to be invested initially in setting up necrotizing enterocolitis companies and thus it restricts various new players to enter the markets.


Another key factor that acts as a barrier towards an increase in necrotizing enterocolitis treatment market share is the lack of skilled healthcare professionals to carry out the diagnosis process which has many times led to the death of the newborn or the infection has returned even after treatment. Also, the side effects associated with drugs that may hamper the growth of the baby have been a major cause of concern in necrotizing enterocolitis treatment.


Another key restraint that has been observed off late is the high cost of necrotizing enterocolitis which bars most of the patients who are not aptly equipped with all the financial resources and also affects the necrotizing enterocolitis market share since it cannot cater to the diverse variety of patients of different sections of the society. The Government also tries to curb the cost of such treatment which also affects the healthcare workers negatively.


Technology Analysis:


The necrotizing enterocolitis market trends have been dedicated towards the use of improved technology in the treatment process since the procedure for necrotizing enterocolitis is based on highly scientific procedures and methods, it is usually carried on with the help of advanced tools and machines.


However, to be more specific, necrotizing enterocolitis procedures involve the use of magnetic resonance imaging systems technique(MRI) which is an image-based screening technique and helps the doctors and healthcare workers to easily locate the infection and provide necessary treatment. The use of modern technology in laboratories, laparoscopy, ultrasounds, and angiographies have been playing an important role in the treatment of necrotizing enterocolitis.


The technological system to be used soon in the necrotizing enterocolitis market involves using robotics and artificial intelligence systems to provide for the specific and timely location of the infection and then proceed with the treatment process and to remove infection by minimizing every threat associated with the treatment and also ensuring that the infection does not return after the treatment.


Study Objectives:



  • To analyze the trends that are prevalent in the global market regions and players that will dominate the global trends and lead the necrotizing enterocolitis market operations towards growth figures that have been predicted by the prominent leaders in the international market and key experts for the ongoing forecast period that ends in 2028.



  • To understand the scale of functioning of the global market segments that are prevalent through their ability to meet the vibrant needs of the target audience for market products and services.



  • To draw a competitive scale amongst the global necrotizing enterocolitis market players and to understand the recent developments of the key necrotizing enterocolitis global market players in the recent past that promise great results to the market for the ongoing forecast period and market trends that end in 2028.


 Segment Overview:


The necrotizing enterocolitis market has been segmented as follows: 


By treatment: 



  • Total Parenteral Nutrition (TPN)

  • gastrointestinal decompression

  • antimicrobial therapy

  • antifungal treatment

  • Paracentesis others


By distribution:



  • direct tender

  • hospital pharmacy

  • retail pharmacy

  • online pharmacy

  • others


By End-User:


  • Hospitals

  • Surgical and ablation Centers

  • Research Institute  


By Region 


North America 


  • The U.S. 

  • Canada 

  • Mexico


Europe 



  • Germany

  • France

  • UK

  • Italy


Asia-Pacific 



  • Japan

  • China 

  • Australia

  • India  


LAMEA 

  • Brazil

  • Saudi

  • Arabia

  • South

  • Africa 


Regional Analysis: 


The global necrotizing enterocolitis market has been divided into four regions where each region has been contributing significantly in terms of its capabilities and population demands. However, among the four regions, the Asia Pacific region has been accounting for the major necrotizing enterocolitis global market share whereby the key drivers towards the growth of the necrotizing enterocolitis industry are developed here, and the population seems to be quite interested in the innovations in terms of new products in the market.


The major necrotizing enterocolitis market revenue is expected to come from countries like China, Japan, Korea, and India. The necrotizing enterocolitis statistics indicate that the major portion of the population in these countries has been of newborn babies and infants who are more likely to be infected with necrotizing enterocolitis. Also, the shift of the people towards health awareness and improvement in healthcare facilities has contributed towards the growth of the market in this region.


The European region has also been experiencing major growth with contributions coming from developed nations such as France, Germany, Denmark, Belgium, etc. since most of the research and development activities are taking place in these countries for the development of a permanent cure for the infection. Also, rapid improvements in technology have led to the widespread development of the necrotizing enterocolitis market in these countries. The North American region is also experiencing vast growth in market shares as the countries in this region have been reaping the benefits of technology thereby maximizing the level of operations and reducing operational cost.


Competitive Landscape: 


The competitive landscape in terms of the necrotizing enterocolitis market has been immense and nail-biting with new players easily entering the market and the existing players making huge investments in this segment.



  •  Abbott Laboratories Inc. (U.S.)

  • Astellas Pharma Inc. (Japan)

  • Bayer HealthCare AG (Germany)

  • Becton, Dickinson, and Company (BD) (U.S.)

  • Bristol-Myers Squibb Company (U.S.)

  • Daiichi Sankyo Company, Ltd. (Japan)

  • Eli Lilly and Co. (U.S.)

  • Enzon Pharmaceuticals, Inc. (U.S.)

  • Hoffmann-La Roche Ltd (Switzerland)

  • GI Supply (U.S.)

  • GlaxoSmithKline Plc (UK)


The key players in the market are more focused on developing future strategies and set themselves as joint ventures to increase the necrotizing enterocolitis market share and size.


Recent Developments:



  • Recently, Prometic Life Sciences Inc. received approval from the US FDA department for its Inter-Alpha-Inhibitor-Proteins which is expected to be a major drug for the treatment of necrotizing enterocolitis.

  • Prolacta Biosciences, a leading manufacturer of medicines and drugs, have continued their developments in terms of producing milk by science for the treatment of infants and for the recovery of critically ill newborns.


 Report Overview:


The Global report helps the investors to gain meaningful information about the necrotizing enterocolitis market and make decisions wisely. The report discusses the steps taken by the market leaders to boost the market growth and inflate market valuation for their good. The report fully summarises the ongoing market scenario in this market which would help the intended audience to seek more information about the market. The objective of the report was to fully summarise the key players in the market and their role in boosting the necrotizing enterocolitis market value. The report also discusses the future growth prospects and the competitive landscape in the necrotizing enterocolitis industry and lays down the expected growth rate of the market along with the hindrances it may face.



Speak to Analyst Ask for Customization